About Us
Respirics is an inhalation drug products company focusing on the
development and commercialization of therapeutic products using the
company's proprietary, customizable Acu-Breathe™ dry powder inhalers
(DPIs). The company's strategy is to develop a suite of inhalation
products for asthma and COPD, and to enter licensing and co-development
programs with large or specialty pharmaceutical companies.
The company has evaluated a number of internal product candidates that
address large respiratory market opportunities. The first drug program
entered its phase I clinical trial at the end of 2007.
Our Acu-Breathe™ DPI technology permits us to develop proprietary inhalation products, with a flexibility unique among inhalation platforms - the devices are customizable to the drug as is required for adequate aerosolization. The multi-dose inhaler products are propellant free, designed to maximize dosing consistency, provide drug protection from ambient moisture, and to give user feedback of dose delivery.